CEACAM5 and neoplasm: The most frequently targeted antigens for these radiolabeled antibody therapies include carcinoembryonic antigens (CEAs), epithelial cell adhesion molecules, and the colon-specific antigen p. Targeting these tumor-associated antigens with radiolabeled antibodies represents a promising strategy for the selective delivery of therapeutic radiation to CRC tumors.